Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02924168
Other study ID # 19109813.1.0000.0068
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 2013
Est. completion date February 2018

Study information

Verified date June 2018
Source University of Sao Paulo
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a double blind randomized clinical trial to evaluate the effect of radial shock waves on functional recovery of the upper limb of patients with sequelae of ischemic strokes in the territory of the middle cerebral artery. A total of 20 patients will be enrolled and will undergo motor, functional and cortical excitability evaluations before and after four weekly sessions of radial shockwaves. 5,000 pulses with a frequency of 15 Hz and 3.5 to 4 bar of air pressure will be applied to the active group, resulting in an energy flux density (EFD) of approximately 0.07 mJ/mm2. The sham group will receive identical treatment, except for the fact that no energy flux will be applied.


Recruitment information / eligibility

Status Completed
Enrollment 22
Est. completion date February 2018
Est. primary completion date February 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Clinical and radiological diagnosis: Magnetic Resonance Imaging (MRI) or Computed Tomography (CT) scan indicating Stroke in the territory of the middle cerebral artery;

- 6 to 24 months after stroke date;

- Stability observed in clinical medical evaluation

- Granting of written informed consent to participate in the study

Exclusion Criteria:

- Individuals with a score lower than 24 on the Mini-mental test;

- Previously documented strokes

- Pregnancy

- Patients treated with botulinum toxin, phenol, alcohol or previous surgeries six months before entering the study

- Bone diseases, pre-existing joint damage, and deformities affecting the patient in a way to interfere with implementation of the proposed therapy

- Psycho-affective disorder that prevents adherence

- Joint pain that occurs within the movement range of therapies

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Active Radial Shockwave
Four weekly sessions of active radial shockwave treatment.
Sham Radial Shockwave
Four weekly sessions of sham radial shockwave treatment.

Locations

Country Name City State
Brazil Instituto de Medicina Fisica e Reabilitacao HCFMUSP Sao Paulo

Sponsors (1)

Lead Sponsor Collaborator
Marta Imamura

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Other Adverse Events (AE) Accountability of occurences of Adverse Events Weekly for two months
Primary Fugl-Meyer Assessment (FMA) Mean change in Fugl Meyer Assessment score after four sessions of Radial Shockwave Therapy (RSWT) as compared to baseline. Change from baseline to 8 weeks
Secondary Visual Analogue Scale (VAS) Multiple changes in VAS Baseline, one and two months
Secondary Esthesiometry - Von Frey Scale Multiple changes in Von Frey Scale Baseline, one and two months
Secondary Upper Limb Modified Ashworth Scale (MAS) Multiple changes in MAS Baseline, one week, two weeks, three weeks, four weeks and two months
Secondary Fugl-Meyer Assessment Changes in Fugl-Meyer Assessment compared to baseline Baseline and two months
Secondary Medical Research Council scale (MRC) Multiple changes in MRC scale Baseline, one and two months
Secondary Hand grip Multiple changes in Hand grip Baseline, one and two months
Secondary Change in fine motor function measured with Finger Tapping (FT) Multiple changes in FT Baseline, one and two months
Secondary Jebsen-Taylor Hand Function Test (JTHFT) Multiple changes in JTHFT Baseline, one and two months
Secondary Purdue Pegboard Test (PPBT) Multiple changes in PPBT Baseline, one and two months
Secondary Robotic kinematic evaluation (RKE) Multiple changes in RKE Baseline, one and two months
Secondary Corticospinal excitability measures with transcranial magnetic stimulation (TMS) Multiple changes in Corticospinal excitability Baseline, one and two months
Secondary Pinch strength testing Pinch strength testing Baseline, one and two months
See also
  Status Clinical Trial Phase
Recruiting NCT05196659 - Collaborative Quality Improvement (C-QIP) Study N/A
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Completed NCT03281590 - Stroke and Cerebrovascular Diseases Registry
Recruiting NCT05518305 - Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
Recruiting NCT06029959 - Stroke and CPAP Outcome Study 3 N/A
Recruiting NCT03728738 - Zero Degree Head Positioning in Hyperacute Large Artery Ischemic Stroke Phase 3
Terminated NCT03396419 - IMPACT- 24col Collateral Blood Flow Assessment Following SPG Stimulation in Acute Ischemic Stroke (ImpACT-24B Sub-Study)
Recruiting NCT05065216 - Treatment of Acute Ischemic Stroke (ReMEDy2 Trial) Phase 2/Phase 3
Recruiting NCT04897334 - Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke N/A
Not yet recruiting NCT06032819 - Differentiating Between Brain Hemorrhage and Contrast
Not yet recruiting NCT06026696 - Cohort of Neurovascular Diseases Treated in the Acute Phase and Followed at Lariboisière
Recruiting NCT02910180 - Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders
Completed NCT02922452 - A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects Phase 1
Completed NCT03554642 - Walkbot Robotic Training for Improvement in Gait Phase 3
Withdrawn NCT01866189 - Identification of Hypoxic Brain Tissues by F-MISO PET in Acute Ischemic Stroke N/A
Recruiting NCT03041753 - Reperfusion Injury After Stroke Study N/A
Completed NCT02549846 - AdminiStration of Statin On Acute Ischemic stRoke patienT Trial Phase 4
Completed NCT01678534 - Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial Phase 2
Completed NCT02610803 - Paroxysmal Atrial Fibrillation in Patients With Acute Ischemic Stroke N/A
Terminated NCT01852201 - POSITIVE Stroke Clinical Trial N/A